Interacting Drugs |
Lansoprazole, amoxicillin, and clarithromycin vs Lapatinib |
Security Level |
|
Mechanism |
Lapatinib: CYP3A4 Inhibitors (Strong) may increase the serum concentration of Lapatinib. |
Management |
If an overlap in therapy cannot be avoided, consider reducing lapatinib dose to 500 mg/day during, and within 1 week of completing, treatment with the strong CYP3A4 inhibitor. |
Lansoprazole, amoxicillin, and clarithromycin vs Lapatinib
Post Review about Lansoprazole, amoxicillin, and clarithromycin vs Lapatinib Click here to cancel reply.
Other Interactions of Lansoprazole, amoxicillin, and clarithromycin
Other Interactions of Lapatinib
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.